Corporate Action3 Oct 2026, 05:50 pm
Fredun Pharma Allots 1.82 Lakh Shares Post Warrant Conversion
AI Summary
Fredun Pharmaceuticals Ltd has allotted 1,82,400 equity shares to non-promoter allottees following the conversion of 60,800 warrants. This conversion was made possible after a 1:2 bonus issue adjusted the warrant entitlements. The allotment follows the payment of the balance consideration by warrant holders. The new shares, with a face value of Rs. 10 each, will rank pari passu with existing equity shares.
Key Highlights
- 1,82,400 equity shares allotted to non-promoters.
- Allotment follows conversion of 60,800 warrants.
- Bonus issue adjusted warrant entitlements and exercise price.
- New shares rank equally with existing equity shares.
Price Impact
More from FREDUN